CABOT CORP (CBT)
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CBT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CBT | Director | 66 | ["Senior Vice President and Chief Financial Officer, PerkinElmer, Inc.", "Finance, business development and investor relations leadership positions, Danaher Corporation", "significant financial expertise and skills in strategic planning", "leadership experience in risk management practices, including cybersecurity and information systems"] | ["Audit (Chair)", "Governance"] | 2025 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NOVT | Director | 67 | ["Former Chief Financial Officer and Senior Vice President of PerkinElmer, Inc., a life sciences diagnostics, discovery and analytical solutions company"] | ["Chair of the Audit Committee","Member of the Compensation Committee","Member of the Transaction Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Director Since: 2018 Committee Memberships: Audit (Chair), Governance Term of Office Expires: 2028 Age: 67 Independent Business Experience: Senior Vice President and Chief Financial Officer, PerkinElmer, Inc., a life sciences diagnostics, discovery and analytical solutions company, 2009 until retirement in 2018 Finance, business development and investor relations leadership positions, Danaher Corporation, a life sciences and industrial conglomerate, 1997 to 2009 Other Public Company Boards: Director, Alkermes, a fully integrated, global biopharmaceutical company (2019 to present; Lead Director since December 2023) Director, Novanta, Inc., a technology partner to medical and advanced industrial OEMs (2021 to present) Director, Sparton Corporation, a provider of design, development and manufacturing services for electromechanical devices (2015 to 2018) Other Boards and Positions: Senior Advisor, Astor Place Holdings, the private investment arm of Select Equity Group, L.P. (2018 to present; interim Chief Executive Officer of portfolio company, Douglas Electrical Components, June 2023 to November 2023) Mr. Wilson has significant financial expertise and skills in strategic planning, investor relations and business development within international public companies, and leadership experience in risk management practices, including in the areas of cybersecurity and information systems.